Related Experiment Video

Updated: Aug 8, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Chronic hepatitis C infection in children

E Broide1, N A Kimchi, E Scapa

  • 1Institute of Gasteroenterology, Asaf Harofeh Medical Center, Zerifin, Israel. efibroide@yahoo.com

Minerva Gastroenterologica E Dietologica
|March 25, 2006
PubMed

Insights

Hepatitis C virus (HCV) in children often presents as mild chronic hepatitis. Maternal-infant transmission is the primary risk factor, with faster disease progression in vertically infected cases.

Area of Science:

  • Pediatric infectious diseases
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection presents unique challenges in pediatric populations regarding transmission, disease progression, and treatment response.
  • While most infected children develop chronic hepatitis, the disease course is typically milder than in adults.

Purpose of the Study:

  • To review the distinct characteristics of Hepatitis C virus infection in children, including transmission routes, natural history, and treatment outcomes.
  • To highlight current understanding and future directions for managing pediatric HCV.

Main Methods:

  • Review of existing literature on pediatric Hepatitis C virus infection.
  • Analysis of transmission dynamics, including perinatal and other routes.
  • Evaluation of disease progression and histopathological findings.
  • Assessment of current and emerging treatment strategies.

Main Results:

  • Maternal-infant transmission is the predominant risk factor for pediatric HCV acquisition.
  • Vertically acquired and post-transfusion HCV infections may progress more rapidly to advanced liver disease compared to other transmission routes.
  • Combination therapy with peginterferon-alfa-2b and ribavirin shows promising tolerability and efficacy in children, though not yet FDA-approved.

Conclusions:

  • Hepatitis C virus infection in children requires specialized consideration due to differences in transmission and disease course.
  • While current treatments show promise, further randomized controlled trials are essential to optimize pediatric HCV management.

More Related Videos

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...